We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Molina (MOH) Outpaces Stock Market Gains: What You Should Know
Read MoreHide Full Article
In the latest trading session, Molina (MOH - Free Report) closed at $144.87, marking a +1.07% move from the previous day. This move outpaced the S&P 500's daily gain of 0.46%. Elsewhere, the Dow gained 0.9%, while the tech-heavy Nasdaq added 0.59%.
Coming into today, shares of the provider of Medicaid-related services had lost 3.21% in the past month. In that same time, the Medical sector gained 1.03%, while the S&P 500 gained 4.04%.
Wall Street will be looking for positivity from MOH as it approaches its next earnings report date. This is expected to be July 30, 2019. In that report, analysts expect MOH to post earnings of $2.56 per share. This would mark year-over-year growth of 13.78%. Meanwhile, our latest consensus estimate is calling for revenue of $4.08 billion, down 16.49% from the prior-year quarter.
For the full year, our Zacks Consensus Estimates are projecting earnings of $10.96 per share and revenue of $16.39 billion, which would represent changes of +3.3% and -13.21%, respectively, from the prior year.
Investors might also notice recent changes to analyst estimates for MOH. These recent revisions tend to reflect the evolving nature of short-term business trends. As such, positive estimate revisions reflect analyst optimism about the company's business and profitability.
Our research shows that these estimate changes are directly correlated with near-term stock prices. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. The Zacks Consensus EPS estimate has moved 0.16% higher within the past month. MOH currently has a Zacks Rank of #1 (Strong Buy).
Investors should also note MOH's current valuation metrics, including its Forward P/E ratio of 13.08. Its industry sports an average Forward P/E of 15.91, so we one might conclude that MOH is trading at a discount comparatively.
It is also worth noting that MOH currently has a PEG ratio of 0.99. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. The Medical - HMOs was holding an average PEG ratio of 1.08 at yesterday's closing price.
The Medical - HMOs industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 10, which puts it in the top 4% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Make sure to utilize Zacks. Com to follow all of these stock-moving metrics, and more, in the coming trading sessions.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Molina (MOH) Outpaces Stock Market Gains: What You Should Know
In the latest trading session, Molina (MOH - Free Report) closed at $144.87, marking a +1.07% move from the previous day. This move outpaced the S&P 500's daily gain of 0.46%. Elsewhere, the Dow gained 0.9%, while the tech-heavy Nasdaq added 0.59%.
Coming into today, shares of the provider of Medicaid-related services had lost 3.21% in the past month. In that same time, the Medical sector gained 1.03%, while the S&P 500 gained 4.04%.
Wall Street will be looking for positivity from MOH as it approaches its next earnings report date. This is expected to be July 30, 2019. In that report, analysts expect MOH to post earnings of $2.56 per share. This would mark year-over-year growth of 13.78%. Meanwhile, our latest consensus estimate is calling for revenue of $4.08 billion, down 16.49% from the prior-year quarter.
For the full year, our Zacks Consensus Estimates are projecting earnings of $10.96 per share and revenue of $16.39 billion, which would represent changes of +3.3% and -13.21%, respectively, from the prior year.
Investors might also notice recent changes to analyst estimates for MOH. These recent revisions tend to reflect the evolving nature of short-term business trends. As such, positive estimate revisions reflect analyst optimism about the company's business and profitability.
Our research shows that these estimate changes are directly correlated with near-term stock prices. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. The Zacks Consensus EPS estimate has moved 0.16% higher within the past month. MOH currently has a Zacks Rank of #1 (Strong Buy).
Investors should also note MOH's current valuation metrics, including its Forward P/E ratio of 13.08. Its industry sports an average Forward P/E of 15.91, so we one might conclude that MOH is trading at a discount comparatively.
It is also worth noting that MOH currently has a PEG ratio of 0.99. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. The Medical - HMOs was holding an average PEG ratio of 1.08 at yesterday's closing price.
The Medical - HMOs industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 10, which puts it in the top 4% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Make sure to utilize Zacks. Com to follow all of these stock-moving metrics, and more, in the coming trading sessions.